Glanzmann thrombasthenia-like syndromes associated with macrothrombocytopenias and mutations in the genes encoding the IIb3 integrin

Seminars in Thrombosis and Hemostasis

Volumn 37, Issue 6, 2011, Pages 698-706

  Nurden, Alan T ^a   Pillois, Xavier ^a   Fiore, Mathieu ^a   Heilig, Roland ^b   Nurden, Paquita ^a  

^a Ctr Geriatrie Ctr Hosp Univ B   (France)

^b CENTRE NATIONAL DE SÉQUENÇAGE   (France)

Author keywords

bleeding syndrome; Glanzmann thrombasthenia; Inherited platelet disorder; integrin IIb3; macrothrombocytopenia

Indexed keywords

FIBRINOGEN RECEPTOR;

ANISOTROPY; ARTICLE; CHROMOSOME 17Q; CYTOPLASM; GENE MUTATION; GLANZMANN DISEASE; HUMAN; MEGAKARYOPOIESIS; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS;

BASE SEQUENCE; BLOOD PLATELETS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; SYNDROME; THROMBASTHENIA; THROMBOCYTOPENIA; THROMBOPOIESIS;

EID: 81755178910     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0031-1291380     Document Type: Article

References (46)

1. Nurden A, George J N. Inherited abnormalities of the platelet membrane: Glanzmann thrombasthenia, Bernard-Soulier syndrome, and other disorders. In: Colman R W. Marder V J. Clowes A W. et al, eds. Haemostasis and Thrombosis Basic Principles & Clinical Practice. 5th ed. Philadelphia, PA Lippincott Williams & Wilkins 2006 987-1010
2. Nurden P, George J N., Nurden A. Inherited thrombocytopenias. In: Colman R W. Marder V J. Clowes A W. et al, eds. Haemostasis and Thrombosis: Basic Principles & Clinical Practice. 5th ed. Philadelphia, PA Lippincott, Williams & Wilkins 2006 975-986
3. Nurden P, Nurden A T. Congenital disorders associated with platelet dysfunctions. Thromb Haemost 2008 99 2 253-263
4. Nurden A T. Glanzmann thrombasthenia. Orphanet J Rare Dis 2006 1 10-18
5. George J N., Caen J P., Nurden A T. Glanzmann's thrombasthenia: the spectrum of clinical disease. Blood 1990 75 7 1383-1395
6. Hodivala-Dilke K M., McHugh K P., Tsakiris D A. et al. 3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J Clin Invest 1999 103 2 229-238
7. Poujol C, Tronik-Le Roux D, Tropel P et al. Ultrastructural analysis of bone marrow hematopoiesis in mice transgenic for the thymidine kinase gene driven by the IIb promoter. Blood 1998 92 6 2012-2023
8. Larson M K., Watson S P. Regulation of proplatelet formation and platelet release by integrin IIb3. Blood 2006 108 5 1509-1514
9. Mazharian A, Thomas S G., Dhanjal T S., Buckley C D., Watson S P. Critical role of Src-Syk-PLC2 signaling in megakaryocyte migration and thrombopoiesis. Blood 2010 116 5 793-800
10. Xiao T, Takagi J, Coller B S., Wang J H., Springer T A. Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature 2004 432 7013 59-67
11. Hughes P E., Diaz-Gonzalez F, Leong L et al. Breaking the integrin hinge. A defined structural constraint regulates integrin signaling. J Biol Chem 1996 271 12 6571-6574
12. Yang J, Ma Y Q., Page R C., Misra S, Plow E F., Qin J. Structure of an integrin alphaIIb3 transmembrane-cytoplasmic heterocomplex provides insight into integrin activation. Proc Natl Acad Sci U S A 2009 106 42 17729-17734
13. Coller B S., Shattil S J. The GPIIb/IIIa Integrin alphaIIbbeta3 odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend. Blood 2008 112 8 3011-3025
14. Hardisty R, Pidard D, Cox A et al. A defect of platelet aggregation associated with an abnormal distribution of glycoprotein IIb-IIIa complexes within the platelet: the cause of a lifelong bleeding disorder. Blood 1992 80 3 696-708
15. Peyruchaud O, Nurden A T., Milet S et al. R to Q amino acid substitution in the GFFKR sequence of the cytoplasmic domain of the integrin IIb subunit in a patient with a Glanzmann's thrombasthenia-like syndrome. Blood 1998 92 11 4178-4187
16. Kunishima S, Kashiwagi H, Ito Y et al. A heterozygous ITGA2B R995W mutation causes constitutive activation of the IIb3 receptor and results in congenital macrothrombocytopenia. J Thromb Haemost 2009 7 Suppl 2 PP-TH-081(abstr)
17. Ghevaert C, Salsmann A, Watkins N A. et al. A nonsynonymous SNP in the ITGB3 gene disrupts the conserved membrane-proximal cytoplasmic salt bridge in the alphaIIbbeta3 integrin and cosegregates dominantly with abnormal proplatelet formation and macrothrombocytopenia. Blood 2008 111 7 3407-3414
18. Schaffner-Reckinger E, Salsmann A, Debili N et al. Overexpression of the partially activated IIb3D723H integrin salt bridge mutant downregulates RhoA activity and induces microtubule-dependent proplatelet-like extensions in Chinese hamster ovary cells. J Thromb Haemost 2009 7 7 1207-1217
19. Jayo A, Conde I, Lastres P et al. L718P mutation in the membrane-proximal cytoplasmic tail of 3 promotes abnormal IIb3 clustering and lipid microdomain coalescence, and associates with a thrombasthenia-like phenotype. Haematologica 2010 95 7 1158-1166
20. Gresele P, Falcinelli E, Giannini S et al. Dominant inheritance of a novel integrin 3 mutation associated with a hereditary macrothrombocytopenia and platelet dysfunction in two Italian families. Haematologica 2009 94 5 663-669
21. Vanhoorelbeke K, De Meyer S F., Pareyn I et al. The novel S527F mutation in the integrin 3 chain induces a high affinity alphaIIbbeta3 receptor by hindering adoption of the bent conformation. J Biol Chem 2009 284 22 14914-14920
22. Kamata T, Ambo H, Puzon-McLaughlin W et al. Critical cysteine residues for regulation of integrin alphaIIbbeta3 are clustered in the epidermal growth factor domains of the 3 subunit. Biochem J 2004 378 Pt 3 1079-1082
23. Ruan J, Schmugge M, Clemetson K J. et al. Homozygous Cys542>Arg substitution in GPIIIa in a Swiss patient with type I Glanzmann's thrombasthenia. Br J Haematol 1999 105 2 523-531
24. Milet-Marsal S, Breillat C, Peyruchaud O et al. Two different 3 cysteine substitutions alter alphaIIb3 maturation and result in Glanzmann thrombasthenia. Thromb Haemost 2002 88 1 104-110
25. Grimaldi C M., Chen F, Scudder L E., Coller B S., French D L. A Cys374Tyr homozygous mutation of platelet glycoprotein IIIa ( 3) in a Chinese patient with Glanzmann's thrombasthenia. Blood 1996 88 5 1666-1675
26. Chen P, Melchior C, Brons N HC et al. Probing conformation changes in the I-like domain and the cysteine-rich repeat of human 3 integrins following disulfide bond disruption by cysteine mutations identification of cysteine 598 involved in IIb3 activation. J Biol Chem 2001 276 38628-38635
27. Mor-Cohen R, Rosenberg N, Peretz H et al. Disulfide bond disruption by a 3-Cys549Arg mutation in six Jordanian families with Glanzmann thrombasthenia causes diminished production of constitutively active IIb3. Thromb Haemost 2007 98 6 1257-1265
28. Ruiz C, Liu C Y., Sun Q H. et al. A point mutation in the cysteine-rich domain of glycoprotein (GP) IIIa results in the expression of a GPIIb-IIIa (alphaIIbbeta3) integrin receptor locked in a high-affinity state and a Glanzmann thrombasthenia-like phenotype. Blood 2001 98 8 2432-2441
29. Wilcox D A., Fang J, Northe P et al. High mortality in mice with platelets expressing integrin IIb3 locked in its high affinity state. Blood (ASH Annual Meeting Abstracts) 2008 112 Abstract 1832
30. Nurden A T., Nurden P. Inherited thrombocytopenias. Haematologica 2007 92 9 1158-1164
31. Salles I I., Feys H B., Iserbyt B F., De Meyer S F., Vanhoorelbeke K, Deckmyn H. Inherited traits affecting platelet function. Blood Rev 2008 22 3 155-172
32. Nakamura F, Pudas R, Heikkinen O et al. The structure of the GPIb-filamin A complex. Blood 2006 107 5 1925-1932
33. Poujol C, Ware J, Nieswandt B, Nurden A T., Nurden P. Absence of GPIbalpha is responsible for aberrant membrane development during megakaryocyte maturation: ultrastructural study using a transgenic model. Exp Hematol 2002 30 4 352-360
34. Eckly A, Strassel C, Freund M et al. Abnormal megakaryocyte morphology and proplatelet formation in mice with megakaryocyte-restricted MYH9 inactivation. Blood 2009 113 14 3182-3189
35. Pecci A, Malara A, Badalucco S et al. Megakaryocytes of patients with MYH9-related thrombocytopenia present an altered proplatelet formation. Thromb Haemost 2009 102 1 90-96
36. Freson K, Devriendt K, Matthijs G et al. Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation. Blood 2001 98 1 85-92
37. Geddis A E. Megakaryopoiesis. Semin Hematol 2010 47 3 212-219
38. Chen Z, Naveiras O, Balduini A et al. The May-Hegglin anomaly gene MYH9 is a negative regulator of platelet biogenesis modulated by the Rho-ROCK pathway. Blood 2007 110 1 171-179
39. Sabri S, Jandrot-Perrus M, Bertoglio J et al. Differential regulation of actin stress fiber assembly and proplatelet formation by 21 integrin and GPVI in human megakaryocytes. Blood 2004 104 10 3117-3125
40. Malara A, Gruppi C, Rebuzzini P et al. Megakaryocyte-matrix interaction within bone marrow: new roles for fibronectin and factor XIII-A. Blood 2011 117 8 2476-2483
41. Zhu J, Luo B H., Barth P, Schonbrun J, Baker D, Springer T A. The structure of a receptor with two associating transmembrane domains on the cell surface: integrin alphaIIbbeta3. Mol Cell 2009 34 2 234-249
42. Metcalf D G., Moore D T., Wu Y et al. NMR analysis of the alphaIIb 3 cytoplasmic interaction suggests a mechanism for integrin regulation. Proc Natl Acad Sci U S A 2010 107 52 22481-22486
43. Mitchell W B., Li J, Murcia M, Valentin N, Newman P J., Coller B S. Mapping early conformational changes in alphaIIb and 3 during biogenesis reveals a potential mechanism for alphaIIbbeta3 adopting its bent conformation. Blood 2007 109 9 3725-3732
44. Raab M, Daxecker H, Edwards R J., Treumann A, Murphy D, Moran N. Protein interactions with the platelet integrin IIb regulatory motif. Proteomics 2010 10 15 2790-2800
45. Nurden A T. Sustaining platelet counts in chronic ITP. Lancet 2011 377 9763 358-360
46. Hourdillé P, Gralnick H R., Heilmann E et al. von Willebrand factor bound to glycoprotein Ib is cleared from the platelet surface after platelet activation by thrombin. Blood 1992 79 8 2011-2021